FACSAria II Cell Sorter for Non-Biohazardous Cells
FACSAria II Cell Sorter for Non-Biohazardous Cells
批准号:
7793915
负责人:
CARL H. JUNE
金额:
$50.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-22 至 2011-07-21
关键词:
AnimalsBiomedical ResearchCancer BiologyCancer CenterCell SeparationCellsDevelopmental BiologyFundingHumanInstitutionLifeMicrobiologyPediatric HospitalsPennsylvaniaPhiladelphiaProductivityRegenerative MedicineResearchResearch PersonnelResearch Project GrantsResourcesScientistSorting - Cell MovementTechnical ExpertiseTechnologyUniversitiesUniversity Hospitalscostinstrumentmedical schoolsprogramspublic health relevance
中文摘要
描述(申请人提供):细胞分选技术在生物医学领域的研究中越来越重要,包括基础发育生物学、癌症生物学、微生物学和再生医学。宾夕法尼亚大学的研究人员,包括宾夕法尼亚大学的艾布拉姆森癌症中心、宾夕法尼亚大学医院、宾夕法尼亚大学医学院和费城儿童医院,正在进行需要多参数流动分选能力的研究项目。这项技术对这些机构正在进行的许多由NIH资助的研究项目的生产率来说变得尤为关键。目前对分类的需求超过了现有仪器的能力。这个项目要求购买一种仪器,它将促进现有技术的发展,降低运营成本,并取代过时的分拣机。致力于分选非人类细胞的Becton Dickinson FACSAria II的加入,将为宾夕法尼亚大学校园内许多科学家的研究项目提供便利。这项提案中的16个主要用户拥有各种各样的NIH资助的研究项目,这些项目将从购买该仪器中受益。已经制定了强有力的机构支助、技术专长和管理计划,以确保有效利用这一资源。
公共卫生相关性:分离可用于生物医学研究的活单个细胞的仪器能力已有重大改进。该项目支持购买一种仪器,该仪器致力于从宾夕法尼亚大学用于开发新疗法的各种动物细胞中分离细胞。
英文摘要
DESCRIPTION (provided by applicant): Cell sorting technology is increasingly important to research in the biomedical field, including basic developmental biology, cancer biology, microbiology and regenerative medicine. Researchers at the University of Pennsylvania, including the Abramson Cancer Center of the University of Pennsylvania, the Hospital of the University of Pennsylvania, the University of Pennsylvania School of Medicine, and the Children's Hospital of Philadelphia, are pursuing research projects that require multiparameter flow sorting capabilities. This technology is becoming particularly critical to the productivity of many ongoing NIH-funded research projects at these institutions. The demand for sorting currently exceeds the capacity of available instruments. This project requests the purchase of an instrument that will advance existing technology, decrease operating costs and replace an outdated sorter. The addition of a Becton Dickinson FACSAria II that is dedicated to sorting non-human cells will facilitate the research programs of many scientists on campus at the University of Pennsylvania. The 16 major users in this proposal have a wide variety of NIH-funded research projects that will benefit from the purchase of this instrument. Strong institutional support, technical expertise and a management plan are in place to assure the efficient utilization of this resource.
PUBLIC HEALTH RELEVANCE: There have been major improvements in the ability of instruments to isolate live single cells that can be used for biomedical research. This project supports the purchase of an instrument that is dedicated to isolate cells from a variety of animal cells that are being used to develop new therapies at the University of Pennsylvania.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering the Next Generation of T Cells
-
批准号:10578324
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2019
-
负责人:CARL H. JUNE
-
依托单位:
Engineering the next generation of T cells
-
批准号:10064451
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2019
-
负责人:CARL H. JUNE
-
依托单位:
Directing the metabolic fate of CAR T cells
-
批准号:10364746
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2018
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
-
批准号:10713199
-
项目类别:
-
资助金额:$278.23万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Project 2: Towards a safe and effective AML treatment strategy using anti-CD33 CAR T cells in combination with CAR-resistant hematopoietic stem cells
-
批准号:10245064
-
项目类别:
-
资助金额:$31.74万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Core A: Administrative and Biostatistics Core
-
批准号:10245066
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Project 2: Towards a safe and effective AML treatment strategy using anti-CD33 CAR T cells in combination with CAR-resistant hematopoietic stem cells
-
批准号:9982244
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
-
批准号:9280418
-
项目类别:
-
资助金额:$289.74万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
-
批准号:10245062
-
项目类别:
-
资助金额:$219.44万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
-
批准号:9982239
-
项目类别:
-
资助金额:$170.2万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Core A: Administrative and Biostatistics Core
-
批准号:9982247
-
项目类别:
-
资助金额:$11.2万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
Core A: Administrative and Clinical Translational Core
-
批准号:10713203
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2017
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8601689
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
Role of co-receptor modified cells in HIV infection
-
批准号:8889623
-
项目类别:
-
资助金额:$156.67万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8989883
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
Role of co-receptor modified cells in HIV infection
-
批准号:8469110
-
项目类别:
-
资助金额:$128.7万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8243893
-
项目类别:
-
资助金额:$51.14万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
Role of co-receptor modified cells in HIV infection
-
批准号:8519303
-
项目类别:
-
资助金额:$131.48万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
CD19 Directed CAR Therapy
-
批准号:8442843
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2012
-
负责人:CARL H. JUNE
-
依托单位:
Core E: Molecular Gene Delivery/Modification Core
-
批准号:8066106
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2010
-
负责人:CARL H. JUNE
-
依托单位:
海外基金